Application 017588
- Type
- NDA
- Sponsor
- CORDEN PHARMA
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | GLEOSTINE | LOMUSTINE | CAPSULE;ORAL | 10MG | Yes | No |
| 002 | GLEOSTINE | LOMUSTINE | CAPSULE;ORAL | 40MG | Yes | No |
| 003 | GLEOSTINE | LOMUSTINE | CAPSULE;ORAL | 100MG | Yes | Yes |
| 004 | GLEOSTINE | LOMUSTINE | CAPSULE;ORAL | 5MG | Yes | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| N017588-001 | GLEOSTINE | LOMUSTINE | 10MG | CAPSULE / ORAL | AB | RLD, Approved before 1982 | |
| N017588-002 | GLEOSTINE | LOMUSTINE | 40MG | CAPSULE / ORAL | AB | RLD, RS, Approved before 1982 | |
| N017588-003 | GLEOSTINE | LOMUSTINE | 100MG | CAPSULE / ORAL | AB | RLD, Approved before 1982 | |
| N017588-004 | GLEOSTINE | LOMUSTINE | 5MG | CAPSULE / ORAL | RLD | 2014-12-19 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| N017588-001 | AB |
| N017588-002 | AB |
| N017588-003 | AB |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-18 06:07:40 | 2026-07 | N017588-001 | GLEOSTINE | 10MG | CAPSULE / ORAL | AB | RLD, Approved before 1982 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N017588-002 | GLEOSTINE | 40MG | CAPSULE / ORAL | AB | RLD, RS, Approved before 1982 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N017588-003 | GLEOSTINE | 100MG | CAPSULE / ORAL | AB | RLD, Approved before 1982 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N017588-004 | GLEOSTINE | 5MG | CAPSULE / ORAL | RLD | 2014-12-19 | caaa826d4ba7… | |
| 2026-02-19 14:30 UTC | 2026-02 | N017588-001 | GLEOSTINE | 10MG | CAPSULE / ORAL | AB | RLD, Approved before 1982 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N017588-002 | GLEOSTINE | 40MG | CAPSULE / ORAL | AB | RLD, RS, Approved before 1982 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N017588-003 | GLEOSTINE | 100MG | CAPSULE / ORAL | AB | RLD, Approved before 1982 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N017588-004 | GLEOSTINE | 5MG | CAPSULE / ORAL | RLD | 2014-12-19 | 011fe1cb6892… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N017588-001 | GLEOSTINE | 10MG | CAPSULE / ORAL | AB | RLD, Approved before 1982 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N017588-002 | GLEOSTINE | 40MG | CAPSULE / ORAL | AB | RLD, RS, Approved before 1982 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N017588-003 | GLEOSTINE | 100MG | CAPSULE / ORAL | AB | RLD, Approved before 1982 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N017588-004 | GLEOSTINE | 5MG | CAPSULE / ORAL | RLD | 2014-12-19 | 31067a03dcf5… | |
| 2025-08-23 18:47 UTC | 2025-08 | N017588-001 | GLEOSTINE | 10MG | CAPSULE / ORAL | RLD, Approved before 1982 | 6a471c1ec25d… | ||
| 2025-08-23 18:47 UTC | 2025-08 | N017588-002 | GLEOSTINE | 40MG | CAPSULE / ORAL | RLD, RS, Approved before 1982 | 6a471c1ec25d… | ||
| 2025-08-23 18:47 UTC | 2025-08 | N017588-003 | GLEOSTINE | 100MG | CAPSULE / ORAL | RLD, Approved before 1982 | 6a471c1ec25d… | ||
| 2025-08-23 18:47 UTC | 2025-08 | N017588-004 | GLEOSTINE | 5MG | CAPSULE / ORAL | RLD | 2014-12-19 | 6a471c1ec25d… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N017588-001 | GLEOSTINE | 10MG | CAPSULE / ORAL | RLD, Approved before 1982 | fd3edfee7708… | ||
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N017588-002 | GLEOSTINE | 40MG | CAPSULE / ORAL | RLD, RS, Approved before 1982 | fd3edfee7708… | ||
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N017588-003 | GLEOSTINE | 100MG | CAPSULE / ORAL | RLD, Approved before 1982 | fd3edfee7708… | ||
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N017588-004 | GLEOSTINE | 5MG | CAPSULE / ORAL | RLD | 2014-12-19 | fd3edfee7708… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N017588-001 | GLEOSTINE | 10MG | CAPSULE / ORAL | RLD, Approved before 1982 | b8a1b40f171c… | ||
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N017588-002 | GLEOSTINE | 40MG | CAPSULE / ORAL | RLD, RS, Approved before 1982 | b8a1b40f171c… | ||
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N017588-003 | GLEOSTINE | 100MG | CAPSULE / ORAL | RLD, Approved before 1982 | b8a1b40f171c… | ||
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N017588-004 | GLEOSTINE | 5MG | CAPSULE / ORAL | RLD | 2014-12-19 | b8a1b40f171c… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N017588-001 | GLEOSTINE | 10MG | CAPSULE / ORAL | RLD, Approved before 1982 | 03ed91905a0d… | ||
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N017588-002 | GLEOSTINE | 40MG | CAPSULE / ORAL | RLD, RS, Approved before 1982 | 03ed91905a0d… | ||
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N017588-003 | GLEOSTINE | 100MG | CAPSULE / ORAL | RLD, Approved before 1982 | 03ed91905a0d… | ||
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N017588-004 | GLEOSTINE | 5MG | CAPSULE / ORAL | RLD | 2014-12-19 | 03ed91905a0d… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N017588-001 | GLEOSTINE | 10MG | CAPSULE / ORAL | RLD, Approved before 1982 | 2680178bc6a6… | ||
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N017588-002 | GLEOSTINE | 40MG | CAPSULE / ORAL | RLD, RS, Approved before 1982 | 2680178bc6a6… | ||
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N017588-003 | GLEOSTINE | 100MG | CAPSULE / ORAL | RLD, Approved before 1982 | 2680178bc6a6… | ||
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N017588-004 | GLEOSTINE | 5MG | CAPSULE / ORAL | RLD | 2014-12-19 | 2680178bc6a6… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N017588-001 | GLEOSTINE | 10MG | CAPSULE / ORAL | RLD, Approved before 1982 | 5bbf6a4d5a75… | ||
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N017588-002 | GLEOSTINE | 40MG | CAPSULE / ORAL | RLD, RS, Approved before 1982 | 5bbf6a4d5a75… | ||
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N017588-003 | GLEOSTINE | 100MG | CAPSULE / ORAL | RLD, Approved before 1982 | 5bbf6a4d5a75… | ||
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N017588-004 | GLEOSTINE | 5MG | CAPSULE / ORAL | RLD | 2014-12-19 | 5bbf6a4d5a75… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N017588-001 | GLEOSTINE | 10MG | CAPSULE / ORAL | RLD, Approved before 1982 | d8e5a09893c0… | ||
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N017588-002 | GLEOSTINE | 40MG | CAPSULE / ORAL | RLD, RS, Approved before 1982 | d8e5a09893c0… | ||
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N017588-003 | GLEOSTINE | 100MG | CAPSULE / ORAL | RLD, Approved before 1982 | d8e5a09893c0… | ||
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N017588-004 | GLEOSTINE | 5MG | CAPSULE / ORAL | RLD | 2014-12-19 | d8e5a09893c0… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-08-18 06:07:40 | 2026-07 | N017588-001 | AB | 1 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N017588-002 | AB | 1 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N017588-003 | AB | 1 | caaa826d4ba7… |
| 2026-02-19 14:30 UTC | 2026-02 | N017588-001 | AB | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N017588-002 | AB | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N017588-003 | AB | 1 | 011fe1cb6892… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N017588-001 | AB | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N017588-002 | AB | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N017588-003 | AB | 1 | 31067a03dcf5… |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | N017588-001 | AB | 1 | a50c72e98297… |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | N017588-002 | AB | 1 | a50c72e98297… |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | N017588-003 | AB | 1 | a50c72e98297… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Lomustine | LOMUSTINE | Wilshire Pharmaceuticals, Inc. | 3c3637fc-4499-4331-a3c4-6969fc86704e | 2026-02-12 | Boxed warning, Warnings, Adverse reactions | 017588 NDA017588 |
| Gleostine | LOMUSTINE | Azurity Pharmaceuticals, Inc. | 3529fe2f-3c23-4862-bb20-b48026957082 | 2025-09-25 | Boxed warning, Warnings, Adverse reactions | 017588 NDA017588 |
| Gleostine | LOMUSTINE | NextSource Biotechnology, LLC | 7f77526b-4c40-409c-82ea-d0f934d89cc2 | 2024-01-23 | Boxed warning, Warnings, Adverse reactions | 017588 NDA017588 58181-3040 58181-3042 58181-3041 |
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 58181-3040 | Gleostine | lomustine | NextSource Biotechnology, LLC | NDA | Current |
| 58181-3040 | Gleostine | lomustine | NextSource Biotechnology, LLC | NDA | Current |
| 58181-3040 | Gleostine | lomustine | NextSource Biotechnology, LLC | NDA | Current |
| 58181-3041 | Gleostine | lomustine | NextSource Biotechnology, LLC | NDA | Current |
| 58181-3041 | Gleostine | lomustine | NextSource Biotechnology, LLC | NDA | Current |
| 58181-3041 | Gleostine | lomustine | NextSource Biotechnology, LLC | NDA | Current |
| 58181-3042 | Gleostine | lomustine | NextSource Biotechnology, LLC | NDA | Current |
| 58181-3042 | Gleostine | lomustine | NextSource Biotechnology, LLC | NDA | Current |
| 58181-3042 | Gleostine | lomustine | NextSource Biotechnology, LLC | NDA | Current |
Documents#
| Document | Submission type | Date |
|---|---|---|
| 64854 | SUPPL | 2020-10-06 |
| 63588 | SUPPL | 2020-06-17 |
| 33317 | SUPPL | 2016-02-02 |
| 13864 | SUPPL | 2016-02-01 |
| 11042 | SUPPL | 2016-01-07 |
| 661 | SUPPL | 2016-01-07 |
| 33316 | SUPPL | 2014-05-28 |
| 660 | SUPPL | 2014-05-22 |
| 11041 | SUPPL | 2013-08-21 |
| 11040 | SUPPL | 2012-11-28 |
| 658 | SUPPL | 2012-11-23 |
| 33315 | SUPPL | 2011-05-16 |
| 659 | SUPPL | 2011-05-16 |
| 33314 | SUPPL | 2009-05-11 |
| 657 | SUPPL | 2009-05-06 |
| 656 | SUPPL | 2003-03-10 |
| 655 | SUPPL | 2002-12-20 |